These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 11252405)
1. Histochemical tracing of bismuth in Helicobacter pylori after in vitro exposure to bismuth citrate. Stoltenberg M; Martiny M; Sørensen K; Rungby J; Krogfelt KA Scand J Gastroenterol; 2001 Feb; 36(2):144-8. PubMed ID: 11252405 [TBL] [Abstract][Full Text] [Related]
2. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study. Tam YH; Yeung CK; Lee KH Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605 [TBL] [Abstract][Full Text] [Related]
3. Tracking bismuth antiulcer drug uptake in single Helicobacter pylori cells. Tsang CN; Ho KS; Sun H; Chan WT J Am Chem Soc; 2011 May; 133(19):7355-7. PubMed ID: 21517022 [TBL] [Abstract][Full Text] [Related]
4. Duodenal ulcer healing rates in a one-year follow-up study with ranitidine bismuth citrate and antibiotics. Wurzer H; Bardhan KD; Marcelino M; Jahnsen J; Allmaier M Hepatogastroenterology; 2001; 48(42):1641-7. PubMed ID: 11813591 [TBL] [Abstract][Full Text] [Related]
5. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial. Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579 [TBL] [Abstract][Full Text] [Related]
6. The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication. Akyildiz M; Akay S; Musoglu A; Tuncyurek M; Aydin A Eur J Intern Med; 2009 Jan; 20(1):53-7. PubMed ID: 19237093 [TBL] [Abstract][Full Text] [Related]
7. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin. Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672 [TBL] [Abstract][Full Text] [Related]
8. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy. Altintaş E; Ulu O; Sezgin O; Aydin O; Camdeviren H Turk J Gastroenterol; 2004 Jun; 15(2):90-3. PubMed ID: 15334317 [TBL] [Abstract][Full Text] [Related]
9. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study. Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114 [TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal and systemic uptake of bismuth in mice after oral exposure. Larsen A; Martiny N; Stoltenberg M; Danscher G; Rungby J Pharmacol Toxicol; 2003 Aug; 93(2):82-90. PubMed ID: 12899670 [TBL] [Abstract][Full Text] [Related]
11. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases. Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848 [TBL] [Abstract][Full Text] [Related]
12. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori. Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori. Thong-Ngam D; Tangkijvanich P; Treeprasertsuk S; Wisedopas N; Kullavanijaya P J Med Assoc Thai; 2002 Oct; 85(10):1054-9. PubMed ID: 12501895 [TBL] [Abstract][Full Text] [Related]
14. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients. Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716 [TBL] [Abstract][Full Text] [Related]
16. Levofloxacin- vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure. Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM Helicobacter; 2007 Feb; 12(1):68-73. PubMed ID: 17241304 [TBL] [Abstract][Full Text] [Related]
17. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease. Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092 [TBL] [Abstract][Full Text] [Related]
18. Effect of Helicobacter pylori eradication on the ulcer recurrence rate after simple closure of perforated duodenal ulcer: retrospective and prospective randomized controlled studies. Kate V; Ananthakrishnan N; Badrinath S Br J Surg; 2001 Aug; 88(8):1054-8. PubMed ID: 11488789 [TBL] [Abstract][Full Text] [Related]
19. The action of bismuth against Helicobacter pylori mimics but is not caused by intracellular iron deprivation. Bland MV; Ismail S; Heinemann JA; Keenan JI Antimicrob Agents Chemother; 2004 Jun; 48(6):1983-8. PubMed ID: 15155188 [TBL] [Abstract][Full Text] [Related]
20. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication. Avidan B; Melzer E; Keller N; Bar-Meir S Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]